SCHEMBL16221027

SCHEMBL16221027

COc1cc(-c2ccc(Cn3cnc4ncccc4c3=O)c(F)c2)ccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.46
MMP13 P45452 1/20 0.40
ROCK1 Q13464 1/20 0.39
TP53 P04637 2/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
KCNH2 Q12809 1/20 0.39
SYK P43405 2/20 0.38
TRPA1 O75762 4/20 0.38
GRK2 P25098 2/20 0.37
CHRM1 P11229 1/20 0.37
NR4A2 P43354 1/20 0.37
DHODH Q02127 1/20 0.37
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16221095 0.89 ROCK2 (0.48) ROCK2MMP13ROCK1SYKTRPA1
SCHEMBL16221024 0.88 TP53 (0.52) ROCK2MMP13TP53GRK2SMN1; SMN2
SCHEMBL16221157 0.85 ROCK2 (0.53) ROCK2MMP13ROCK1TRPA1GRK2
SCHEMBL16221022 0.85 GRK2 (0.50) TP53LMNAPOLBKCNH2TRPA1
SCHEMBL16221129 0.85 ROCK2 (0.41) ROCK2MMP13ROCK1TP53KCNH2
SCHEMBL16221023 0.85 LMNA (0.40) TP53LMNAPOLBTRPA1GRK2
SCHEMBL17677797 0.84 LMNA (0.46) TP53LMNAPOLBTRPA1GRK2
SCHEMBL16221267 0.82 ROCK2 (0.60) ROCK2MMP13ROCK1TRPA1GRK2
SCHEMBL16221013 0.82 CHRM1 (0.49) ROCK2MMP13ROCK1TP53GRK2
SCHEMBL17677791 0.81 LMNA (0.46) TP53LMNAPOLBTRPA1CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9540371-B2 Substituted quinazolin-4(3H)-ones, pyrido[3,4-d]pyrimidin-4(3H)-ones, pyrido[3,2-d]pyrimidin-4(3H)-ones and pyrido[2,3-d]pyrimidin-4(3H)-ones as positive allosteric modulators of muscarinic acetycholine receptor M1 VANDERBILT UNIVERSITY (US) 2017-01-10 US disclosed
US-9540371-B2 Substituted quinazolin-4(3H)-ones, pyrido[3,4-d]pyrimidin-4(3H)-ones, pyrido[3,2-d]pyrimidin-4(3H)-ones and pyrido[2,3-d]pyrimidin-4(3H)-ones as positive allosteric modulators of muscarinic acetycholine receptor M1 VANDERBILT UNIVERSITY (US) 2017-01-10 US disclosed
US-20160102090-A1 SUBSTITUTED 3-BENZYLQUINOXALIN-4(3H)-ONE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYCHOLINE RECEPTOR M1 VANDERBILT UNIVERSITY (US) 2016-04-14 US disclosed
US-20160102090-A1 SUBSTITUTED 3-BENZYLQUINOXALIN-4(3H)-ONE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYCHOLINE RECEPTOR M1 VANDERBILT UNIVERSITY (US) 2016-04-14 US disclosed
WO-2014179237-A1 SUBSTITUTED 3-BENZYLQUINOXALIN-4(3H)-ONE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYCHOLINE RECEPTOR M1 VANDERBILT UNIVERSITY (US) 2014-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160102090-A1 SUBSTITUTED 3-BENZYLQUINOXALIN-4(3H)-ONE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYCHOLINE RECEPTOR M1 CHRM1, CHRM3, CHRM4 ROCK2 962/4885MMP13 4629/4885ROCK1 476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.